Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.39 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13989231 | 1.00 | ALDH1A1 (0.50) | ALDH1A1MAPTHTTHSD17B10USP2 | |
| SCHEMBL18127060 | 1.00 | ALDH1A1 (0.50) | ALDH1A1MAPTHTTHSD17B10USP2 | |
| SCHEMBL12284086 | 1.00 | ALDH1A1 (0.50) | ALDH1A1MAPTHTTHSD17B10USP2 | |
| SCHEMBL18539440 | 0.89 | ALDH1A1 (0.60) | ALDH1A1MAPTHTTHSD17B10USP2 | |
| SCHEMBL12744298 | 0.89 | ALDH1A1 (0.60) | ALDH1A1MAPTHTTHSD17B10USP2 | |
| SCHEMBL16210943 | 0.86 | ALDH1A1 (0.53) | ALDH1A1MAPTHTTHSD17B10USP2 | |
| SCHEMBL28416943 | 0.84 | ALDH1A1 (0.50) | ALDH1A1MAPTHTTHSD17B10USP2 | |
| SCHEMBL28419881 | 0.84 | ALDH1A1 (0.55) | ALDH1A1MAPTHTTHSD17B10USP2 | |
| SCHEMBL12284562 | 0.83 | ALDH1A1 (0.43) | ALDH1A1MAPTHTTHSD17B10USP2 | |
| SCHEMBL18126828 | 0.83 | ALDH1A1 (0.43) | ALDH1A1MAPTHTTHSD17B10USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12195587-B2 | Synthesis of a biocompatible, biodegradable, and tunable shape memory polymer triggered at body temperature | SHAPE MEMORY POLYMERS INC (CA) | 2025-01-14 | — | — | US | claimed |
| US-20230312820-A1 | SYNTHESIS OF A BIOCOMPATIBLE, BIODEGRADABLE, AND TUNABLE SHAPE MEMORY POLYMER TRIGGERED AT BODY TEMPERATURE | SHAPE MEMORY POLYMERS INC (CA) | 2023-10-05 | — | — | US | claimed |
| WO-2025085489-A1 | GSPT1-DEGRADING COMPOUNDS, ANTI-CD33 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES AND USES THEREOF | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-04-24 | — | — | WO | disclosed |
| US-12195587-B2 | Synthesis of a biocompatible, biodegradable, and tunable shape memory polymer triggered at body temperature | SHAPE MEMORY POLYMERS INC (CA) | 2025-01-14 | — | — | US | disclosed |
| US-20240293585-A1 | HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS | KODIAK SCIENCES INC. | 2024-09-05 | — | — | US | disclosed |
| WO-2024160696-A2 | CURABLE COMPOSITION, 3D-PRINTED OBJECT FORMED THEREFROM AND PROCESS OF FORMING THE SAME | BASF SE (DE) | 2024-08-08 | — | — | WO | disclosed |
| US-20240197810-A1 | MULTIFUNCTIONAL ZWITTERIONIC POLYMER CONJUGATES | KODIAK SCIENCES INC. | 2024-06-20 | — | — | US | disclosed |
| US-11939428-B2 | Polyimides | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2024-03-26 | — | — | US | disclosed |
| US-11819531-B2 | Multifunctional zwitterionic polymer conjugates | KODIAK SCIENCES INC. (US) | 2023-11-21 | — | — | US | disclosed |
| EP-3659591-B1 | MULTIFUNCTIONAL ZWITTERIONIC POLYMER CONJUGATES | KODIAK SCIENCES INC (US) | 2023-10-25 | — | — | EP | disclosed |
| US-20230312820-A1 | SYNTHESIS OF A BIOCOMPATIBLE, BIODEGRADABLE, AND TUNABLE SHAPE MEMORY POLYMER TRIGGERED AT BODY TEMPERATURE | SHAPE MEMORY POLYMERS INC (CA) | 2023-10-05 | — | — | US | disclosed |
| WO-2011075736-A1 | MULTIFUNCTIONAL ZWITTERIONIC POLYMER CONJUGATES | OLIGASIS (US) | 2011-06-23 | — | — | WO | disclosed |
| US-20100261841-A1 | Intermediates Useful in the Preparation of Maleimide Functionalized Polymers | NEKTAR THERAPEUTICS (US) | 2010-10-14 | — | — | US | disclosed |
| US-20100261841-A1 | Intermediates Useful in the Preparation of Maleimide Functionalized Polymers | NEKTAR THERAPEUTICS (US) | 2010-10-14 | — | — | US | disclosed |
| US-20100261841-A1 | Intermediates Useful in the Preparation of Maleimide Functionalized Polymers | NEKTAR THERAPEUTICS (US) | 2010-10-14 | — | — | US | disclosed |
| US-7790835-B2 | Water soluble, non-peptidic polymer covalently attached to a Diels-Alder bicyclic or tricyclic imide ring; chemical intermediates | NEKTAR THERAPEUTICS (US) | 2010-09-07 | — | — | US | disclosed |
| US-7790835-B2 | Water soluble, non-peptidic polymer covalently attached to a Diels-Alder bicyclic or tricyclic imide ring; chemical intermediates | NEKTAR THERAPEUTICS (US) | 2010-09-07 | — | — | US | disclosed |
| US-7790835-B2 | Water soluble, non-peptidic polymer covalently attached to a Diels-Alder bicyclic or tricyclic imide ring; chemical intermediates | NEKTAR THERAPEUTICS (US) | 2010-09-07 | — | — | US | disclosed |
| US-20080300348-A1 | Polymer | WARWICK EFFECT POLYMERS LIMITED | 2008-12-04 | — | — | US | disclosed |
| US-20050176922-A1 | Water soluble, non-peptidic polymer covalently attached to a Diels-Alder bicyclic or tricyclic imide ring; chemical intermediates | NEKTAR THERAPEUTICS | 2005-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240293585-A1 | HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS | ACP1, PHOSPHO1, PARG | ALDH1A1 4348/4885MAPT 2483/4885HTT 1801/4885 |
| US-20240197810-A1 | MULTIFUNCTIONAL ZWITTERIONIC POLYMER CONJUGATES | PHOSPHO1, MSN, ZW10 | ALDH1A1 4195/4885MAPT 2256/4885HTT 2809/4885 |
| US-11819531-B2 | Multifunctional zwitterionic polymer conjugates | PHOSPHO1, MSN, ZW10 | ALDH1A1 4195/4885MAPT 2256/4885HTT 2809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.